On October 5, 2020, we received a long-awaited permit from the Main Pharmaceutical Inspectorate for the production of a veterinary medicinal product of cell therapy, which is an important milestone in the development of our company.
Obtaining the permit ranks us among the few companies in the world with production facilities that meet the requirements of the market regulator for the production of veterinary biological drugs.
Thanks to the permit, we will be able to produce a series of products intended for clinical trials.
